Company
Headquarters: Zhubei, Taiwan
CEO: Mr. Ih-Houng Loh
TW$5.32 Billion
TWD as of Jan. 1, 2025
US$162.1 Million
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $216.79 B |
| EssilorLuxottica SA | $116.96 B |
| Becton, Dickinson and Company | $69.74 B |
| HOYA Corp | $45.26 B |
| Alcon Inc. | $41.55 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
ICARES Medicus, Inc. engages in the research and development, manufacture, and sale of ophthalmic medical materials. The company provides nanomedical lubricious coatings and various surface treatments for implantable or interventional medical devices; intraocular lenses for the treatment of cataracts, myopia, hyperopia, presbyopia, or astigmatism; and related technical services. It has operations in the United States, England, Japan, Taiwan, Spain, Korea, Hungary, Israel, China, and internationally. ICARES Medicus, Inc. was incorporated in 2011 and is based in Zhubei, Taiwan.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
ICARES Medicus, Inc. has the following listings and related stock indices.
Stock: TWSE: 6612 wb_incandescent